Sharon L Nichols1, Sean S Brummel, Renee A Smith, Patricia A Garvie, Scott J Hunter, Kathleen M Malee, Betsy L Kammerer, Megan L Wilkins, Richard Rutstein, Katherine Tassiopoulos, Miriam C Chernoff, Claude A Mellins. 1. From the *Department of Neurosciences, University of California, San Diego, La Jolla, CA; †Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA; ‡Department of Pediatrics, University of Illinois at Chicago, Chicago, IL; §Research Department, Children's Diagnostic & Treatment Center, Fort Lauderdale, FL; ¶Departments of Psychiatry & Behavioral Neuroscience and Pediatrics, University of Chicago; ‖Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL; **Department of Psychiatry, Boston Children's Hospital, Boston, MA; ††Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN; ‡‡Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; §§Department of Epidemiology, Harvard T.H. Chan School of Public Health; ¶¶Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA; and ‖‖Departments of Psychiatry and Sociomedical Sciences, Columbia University, New York, NY.
Abstract
BACKGROUND: Perinatal HIV (PHIV) infection may place youth at risk for impairments in executive functioning (EF). We examined associations of EF with HIV infection, disease severity and other factors among youth with PHIV and perinatally HIV-exposed, uninfected youth (PHEU). METHODS: Within the US-based Pediatric HIV/AIDS Cohort Study, 354 PHIV and 200 PHEU youth completed a standardized EF measure (Children's Color Trails Test, CCTT) and youth and/or caregivers completed a questionnaire measuring everyday EF (Behavior Rating Inventory of Executive Function, BRIEF). Covariates included HIV status, current and historical disease severity, demographic and caregiver variables and other cognitive measures. Analyses used linear and logistic regression and proportional odds models. RESULTS: No significant HIV status group differences were found on CCTT scores. Caregiver BRIEF ratings indicated significantly fewer problems for PHIV than PHEU youth. However, PHIV youth with past encephalopathy self-endorsed significantly greater metacognitive (ie, cognitive regulation) problems on the BRIEF and performed more slowly on the CCTT than PHEU youth. CCTT and caregiver BRIEF scores had significant associations with indicators of past and present disease severity. Both PHIV and PHEU had significantly worse scores than population means on CCTT and BRIEF; scores had significant associations with demographic covariates. CONCLUSIONS: Youth with PHIV show EF problems likely associated with risk factors other than HIV. However, cognitive slowing and self-reported metacognitive problems were evident in PHIV youth with a history of encephalopathy. Assessment and treatment of EF impairment may be important to identifying PHIV youth at particular risk for poor health and behavioral outcomes.
BACKGROUND: Perinatal HIV (PHIV) infection may place youth at risk for impairments in executive functioning (EF). We examined associations of EF with HIV infection, disease severity and other factors among youth with PHIV and perinatally HIV-exposed, uninfected youth (PHEU). METHODS: Within the US-based Pediatric HIV/AIDS Cohort Study, 354 PHIV and 200 PHEU youth completed a standardized EF measure (Children's Color Trails Test, CCTT) and youth and/or caregivers completed a questionnaire measuring everyday EF (Behavior Rating Inventory of Executive Function, BRIEF). Covariates included HIV status, current and historical disease severity, demographic and caregiver variables and other cognitive measures. Analyses used linear and logistic regression and proportional odds models. RESULTS: No significant HIV status group differences were found on CCTT scores. Caregiver BRIEF ratings indicated significantly fewer problems for PHIV than PHEU youth. However, PHIV youth with past encephalopathy self-endorsed significantly greater metacognitive (ie, cognitive regulation) problems on the BRIEF and performed more slowly on the CCTT than PHEU youth. CCTT and caregiver BRIEF scores had significant associations with indicators of past and present disease severity. Both PHIV and PHEU had significantly worse scores than population means on CCTT and BRIEF; scores had significant associations with demographic covariates. CONCLUSIONS: Youth with PHIV show EF problems likely associated with risk factors other than HIV. However, cognitive slowing and self-reported metacognitive problems were evident in PHIV youth with a history of encephalopathy. Assessment and treatment of EF impairment may be important to identifying PHIV youth at particular risk for poor health and behavioral outcomes.
Authors: Ned Sacktor; Richard L Skolasky; Christopher Cox; Ola Selnes; James T Becker; Bruce Cohen; Eileen Martin; Eric N Miller Journal: J Neurovirol Date: 2010-10 Impact factor: 2.643
Authors: Staci C Martin; Pamela L Wolters; Mary Anne Toledo-Tamula; Steven L Zeichner; Rohan Hazra; Lucy Civitello Journal: Dev Neuropsychol Date: 2006 Impact factor: 2.253
Authors: Sanneke Koekkoek; Leo M J de Sonneville; Tom F W Wolfs; Rob Licht; Sibyl P M Geelen Journal: Eur J Paediatr Neurol Date: 2007-10-18 Impact factor: 3.140
Authors: Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant Journal: J Neurovirol Date: 2010-12-21 Impact factor: 2.643
Authors: Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols Journal: Pediatr Infect Dis J Date: 2017-08 Impact factor: 2.129
Authors: Katrina D Hermetet-Lindsay; Katharine F Correia; Paige L Williams; Renee Smith; Kathleen M Malee; Claude A Mellins; Richard M Rutstein Journal: AIDS Behav Date: 2017-09
Authors: Sharon L Nichols; Miriam C Chernoff; Kathleen M Malee; Patricia A Sirois; Steven P Woods; Paige L Williams; Cenk Yildirim; Dean Delis; Betsy Kammerer Journal: J Pediatric Infect Dis Soc Date: 2016-12 Impact factor: 3.164
Authors: Patricia A Sirois; Miriam C Chernoff; Kathleen M Malee; Patricia A Garvie; Lynnette L Harris; Paige L Williams; Steven P Woods; Molly L Nozyce; Betsy L Kammerer; Cenk Yildirim; Sharon L Nichols Journal: J Pediatric Infect Dis Soc Date: 2016-12 Impact factor: 3.164
Authors: Katherine S Elkington; Zachary Peters; C Jean Choi; Amelia Bucek; Cheng-Shiun Leu; Elaine J Abrams; Claude A Mellins Journal: AIDS Behav Date: 2018-10
Authors: Lynnette L Harris; Miriam C Chernoff; Sharon L Nichols; Paige L Williams; Patricia A Garvie; Cenk Yildirim; Stephen R McCauley; Steven Paul Woods Journal: Child Neuropsychol Date: 2017-08-07 Impact factor: 2.500
Authors: Kathleen M Malee; Miriam C Chernoff; Patricia A Sirois; Paige L Williams; Patricia A Garvie; Betsy L Kammerer; Lynnette L Harris; Molly L Nozyce; Cenk Yildirim; Sharon L Nichols Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Sharon L Nichols; Sean Brummel; Kathleen M Malee; Claude A Mellins; Anna-Barbara Moscicki; Renee Smith; Anai M Cuadra; Kendall Bryant; Cheryl Anne Boyce; Katherine K Tassiopoulos Journal: AIDS Behav Date: 2021-02-22